We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Method to Reveal Bacterial Reaction to Antibiotics in Five Minutes Could Help Create Rapid Molecular Test

By LabMedica International staff writers
Posted on 24 May 2023

Severely sick patients suffering from bacterial infections often require immediate treatment to prevent serious health complications, making it vital for physicians to quickly identify the appropriate antibiotic. More...

However, existing approaches to determining antibiotic resistance can involve extensive periods, sometimes hours or even days. This has led to the frequent prescription of broad-spectrum antibiotics, heightening the risk of antibiotic resistance. Now, a simple method has been developed that can detect bacterial response to antibiotics within just five minutes.

Researchers at Karolinska Institutet (Solna, Sweden) set out to reduce the unwarranted use of antibiotics by devising a rapid method to assess how bacteria react to different environmental conditions, including antibiotic administration. They developed the 5PSeq method, which relies on sequencing the messenger RNA (mRNA) that is broken down by the bacteria as they synthesize proteins. The researchers employed the 5PSeq method to examine mRNA breakdown intermediates in isolated species and complex microbiomes. They tested the method on 96 bacterial species from diverse phyla in complex clinical samples, such as fecal, gut, and vaginal samples, as well as compost samples. In a matter of minutes, the researchers were able to determine whether the bacteria were reacting to the antibiotic treatment; the effect was most noticeable after about half an hour.

By utilizing metadegradome sequencing - parallel analysis of RNA ends - the team characterized 5′P mRNA decay intermediates in all 96 species, including Bacillus subtilis, Escherichia coli, Synechocystis spp., and Prevotella copri. They discovered co-translational mRNA degradation to be common among bacteria and generated a degradome atlas for the 96 species, facilitating the further study of RNA degradation mechanisms in bacteria. In addition to measuring antibiotic resistance, the method can be employed to help scientists understand how bacteria manage diverse environmental pressures, and how they interact both with each other and with their hosts. The researchers plan to continue investigating complex intestinal samples to gain deeper insights into the interactions of bacterial communities in the gut and their effects on human health. The aim is to refine the method and develop a rapid molecular test for clinical application.

“We demonstrate that metadegradome sequencing provides fast, species-specific posttranscriptional characterization of responses to drug or environmental perturbations,” the researchers wrote. “Our work paves the way for the application of metadegradome sequencing to investigation of posttranscriptional regulation in unculturable species and complex microbial communities.”

Related Links:
Karolinska Institutet 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.